Chart calendar Monte Rosa Therapeutics, Inc.

0.oFkDCKdgoRenAYw1yzV9B9ZDlHYa5HmeabUZVnFGYMA.52BobZQkxUTeZP17lAUQdr47_0JtjRfLK8chHxUhJIrBKks87QfzUc044w~308914a47fc4d081fa542b3cdafbc3eb

Upcoming events on Monte Rosa Therapeutics, Inc.

No events available

Past events on Monte Rosa Therapeutics, Inc.

01/10/2026

Information meeting

20:00
11/06/2026

Présentation aux Actionnaires / Analystes

20:30
11/06/2026

Annual General Meeting

20:30
07/01/2026

Information meeting

21:00
16/12/2025

Information meeting

21:00

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
0,00
15,1
-
75,6
59,8
26.51%
124
136
-9.37%

102


62,2


104

EBITDA
Million USD
Released
Forecast
Spread
-137
-93,4
-46.8%
-73,0
-143
48.9%
0,00
0,00
-

-151


-122


-175

EBIT
Million USD
Released
Forecast
Spread
-143
-131
-9.04%
-81,1
-89,3
9.18%
-54,2
-34,7
-56.23%

-128


-210


-202

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-135
-123
-9.41%
-70,1
-78,8
11.01%
-39,7
-20,7
-91.89%

-105


-193


-186

Net income
Million USD
Released
Forecast
Spread
-135
-124
-9.53%
-72,7
-78,9
7.87%
-38,6
-21,5
-79.63%

-107


-194


-189

EPS
USD
Released
Forecast
Spread
-2,63
-2,42
-8.79%
-0,98
-1,25
21.87%
-0,46
-0,26
-78.28%

-1,06


-1,83


-1,63

Announcement Date14/03/2420/03/2517/03/26-

Quarterly results

Fiscal PeriodSeptember 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
84,9
13,6
526.01%
23,2
7,37
214.67%
12,8
7,37
73.21%
2,78
15,5
-82.07%
4,21
11,4
-63.02%
8,97
12,9
-30.36%
54,4
33,9
60.42%

32,1


3,92


3,92


4,67


4,67

EBITDA
Million USD
Released
Forecast
Spread


















0,21
-6,94
102.95%

-51,1













EBIT
Million USD
Released
Forecast
Spread
44,0
-32,2
236.91%
-15,6
-33,0
52.94%
-33,0
-32,2
-2.43%
-49,7
-30,2
-64.52%
-50,0
-42,5
-17.87%
-49,1
-43,4
-13.1%
-1,94
-27,0
92.82%

-25,7


-63,9


-67,1


-68,4


-73,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
47,7
-29,6
261.38%
-11,1
-29,8
62.78%
-30,3
-28,7
-5.52%
-46,1
-27,0
-70.46%
-44,5
-38,0
-17.08%
-43,2
-38,5
-12.14%
3,78
-21,6
117.46%

-20,4


-59,4


-63,1


-64,7


-70,2

Net income
Million USD
Released
Forecast
Spread
46,9
-29,6
258.6%
-12,3
-29,8
58.76%
-27,1
-28,7
5.56%
-46,1
-28,4
-62.35%
-44,5
-38,0
-17.22%
-43,4
-38,5
-12.68%
3,06
-21,9
114%

-21,7


-59,5


-63,3


-64,8


-70,3

EPS
USD
Released
Forecast
Spread
0,57
-0,34
269.28%
-0,15
-0,38
60.17%
-0,33
-0,37
10.02%
-0,55
-0,35
-56.73%
-0,45
-0,38
-18.53%
-0,43
-0,38
-12.73%
0,03
-0,21
113.97%

-0,21


-0,47


-0,49


-0,48


-0,52

Announcement Date08/05/2507/08/2506/11/2517/03/2607/05/2606/08/2605/11/26-----
16/11/2026

Information meeting

21:30
16/11/2026

Extraordinary General Meeting

09:30
17/11/2026

Information meeting

01:00
18/11/2026

Annual General Meeting

24/11/2026

Earnings presentation

15:00
24/11/2026

Earnings presentation

22:00
24/11/2026

Earnings release - Q3 2026

25/11/2026

Earnings release - Q3 2026

26/11/2026

Analyst/Investor Day

16:30
01/12/2026

Analyst/Investor Day

22:00

Past sector events for Monte Rosa Therapeutics, Inc.

Today

Information meeting

21:00
13/11/2026

Ex-dividend date - 0.08 USD

13:00
13/11/2026

Earnings presentation

13/11/2026

Earnings release - Q3 2026

P
13/11/2026

Analyst/Investor Day

21:30
12/11/2026

Earnings presentation

21:00
12/11/2026

Earnings release - Q3 2026

12/11/2026

Analyst/Investor Day

21:00
12/11/2026

Earnings release - Q3 2026

12/11/2026

Ex-dividend date - 0.24 GBX

13:00

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Monte Rosa Therapeutics, Inc.

Quarterly earnings - Rate of surprise

Rate of surprise - EPS - Quarterly - Monte Rosa Therapeutics, Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Monte Rosa Therapeutics, Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Monte Rosa Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. GLUE Stock
  4. Calendar Monte Rosa Therapeutics, Inc.